Current and Future Applications of Artificial Intelligence in Coronary Artery Disease

Nitesh Gautam1, Prachi Saluja1, Abdallah Malkawi2

  • 1Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Insights

Artificial intelligence (AI) is transforming cardiovascular medicine, particularly in coronary artery disease (CAD) management. This review highlights AI

Area of Science:

  • Cardiovascular Medicine
  • Artificial Intelligence
  • Machine Learning

Background:

  • Cardiovascular diseases (CVDs) cause significant morbidity, mortality, and economic burden globally.
  • Coronary artery disease (CAD), a subset of CVDs, affects millions and incurs substantial healthcare costs.
  • Artificial intelligence (AI) and machine learning (ML) have emerged as powerful tools in cardiovascular medicine.

Purpose of the Study:

  • To review recent advances in AI applications for coronary artery disease.
  • To identify current limitations of AI in CAD management.
  • To discuss future perspectives for AI in the field of CAD.

Main Methods:

  • Literature review of AI and ML applications in coronary artery disease.
  • Analysis of AI's role in risk prediction, imaging, and treatment decision support.
  • Synthesis of current challenges and future research directions.

Main Results:

  • AI demonstrates promise in areas such as genetic interaction analysis, clinical risk prediction models, and advanced cardiac imaging for CAD.
  • AI tools are being developed for automatic interpretation of heart rhythm disorders and assisting clinical decision-making.
  • AI applications show potential for improving mortality outcomes in patients with CAD.

Conclusions:

  • AI is rapidly advancing cardiovascular medicine, offering innovative solutions for coronary artery disease.
  • Addressing current limitations and exploring future perspectives are crucial for maximizing AI's impact on CAD.
  • AI holds significant potential to enhance the diagnosis, treatment, and outcomes of coronary artery disease.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
200
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
142
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
70
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59